OBJECTIVE: The purpose of this study was to use quantitative analysis to assess MRI and washout CT in the diagnosis of pheochromocytoma versus adenoma. MATERIALS AND METHODS: Thirty-four pheochromocytomas (washout CT, 5; MRI, 24; both MRI and CT, 5) resected between 2003 and 2014 were compared with 39 consecutive adenomas (washout CT, 9; MRI, 29; both MRI and CT, 1). A blinded radiologist measured unenhanced attenuation, 70-second peak CT enhancement, 15-minute relative and absolute percentage CT washout, chemical-shift signal intensity index, adrenal-to-spleen signal intensity ratio, T2-weighted signal intensity ratio, and AUC of the contrast-enhanced MRI curve. Comparisons between groups were performed with multivariate and ROC analyses. RESULTS: There was no difference in age or sex between the groups (p > 0.05). For CT, pheochromocytomas were larger (4.2 ± 2.5 [SD] vs 2.3 ± 0.9 mm; p = 0.02) and had higher unenhanced attenuation (35.7 ± 6.8 HU [range, 24-48 HU] vs 14.0 ± 20.9 HU [range, -19 to 52 HU]; p = 0.002), greater 70-second peak CT enhancement (92.8 ± 31.1 HU [range, 41.0-143.1 HU] vs 82.6 ± 29.9 HU [range, 50.0-139.0 HU ]; p = 0.01), lower relative washout CT (21.7 ± 24.7 [range, -29.3 to 53.7] vs 65.3 ± 22.3 [range, 32.9-115.3]; p = 0.002), and lower absolute washout CT (31.9 ± 42.8 [range, -70.6 to 70.2] vs 76.9 ± 10.3 [range, 60.3-89.6]; p = 0.001). Thirty percent (3/10) of pheochromocytomas had absolute CT washout in the adenoma range (> 60%). For MRI, pheochromocytomas were larger (5.0 ± 4.2 vs 2.0 ± 0.7 mm; p = 0.003) and had a lower chemical-shift signal intensity index and higher adrenal-to-spleen signal intensity ratio (-3.5% ± 14.3% [range, -56.3% to 12.2%] and 1.1% ± 0.1% [range, 0.9-1.3%] vs 47.3% ± 27.8% [range, -9.4% to 86.0%] and 0.51% ± 0.27% [range, 0.13-1.1%]) (p < 0.001) and higher T2-weighted signal intensity ratio (4.4 ± 2.4 vs 1.8 ± 0.8; p < 0.001). There was no statistically significant difference in contrast-enhanced MRI AUC (288.9 ± 265.3 vs 276.2 ± 129.9 seconds; p = 0.96). The ROC AUC for T2-weighted signal intensity ratio was 0.91 with values greater than 3.8 diagnostic of pheochromocytoma. CONCLUSION: In this study, the presence of intracellular lipid on unenhanced CT or chemical-shift MR images was diagnostic of adrenal adenoma. Elevated T2-weighted signal intensity ratio was specific for pheochromocytoma but lacked sensitivity. There was overlap in all other MRI and CT washout parameters.
OBJECTIVE: The purpose of this study was to use quantitative analysis to assess MRI and washout CT in the diagnosis of pheochromocytoma versus adenoma. MATERIALS AND METHODS: Thirty-four pheochromocytomas (washout CT, 5; MRI, 24; both MRI and CT, 5) resected between 2003 and 2014 were compared with 39 consecutive adenomas (washout CT, 9; MRI, 29; both MRI and CT, 1). A blinded radiologist measured unenhanced attenuation, 70-second peak CT enhancement, 15-minute relative and absolute percentage CT washout, chemical-shift signal intensity index, adrenal-to-spleen signal intensity ratio, T2-weighted signal intensity ratio, and AUC of the contrast-enhanced MRI curve. Comparisons between groups were performed with multivariate and ROC analyses. RESULTS: There was no difference in age or sex between the groups (p > 0.05). For CT, pheochromocytomas were larger (4.2 ± 2.5 [SD] vs 2.3 ± 0.9 mm; p = 0.02) and had higher unenhanced attenuation (35.7 ± 6.8 HU [range, 24-48 HU] vs 14.0 ± 20.9 HU [range, -19 to 52 HU]; p = 0.002), greater 70-second peak CT enhancement (92.8 ± 31.1 HU [range, 41.0-143.1 HU] vs 82.6 ± 29.9 HU [range, 50.0-139.0 HU ]; p = 0.01), lower relative washout CT (21.7 ± 24.7 [range, -29.3 to 53.7] vs 65.3 ± 22.3 [range, 32.9-115.3]; p = 0.002), and lower absolute washout CT (31.9 ± 42.8 [range, -70.6 to 70.2] vs 76.9 ± 10.3 [range, 60.3-89.6]; p = 0.001). Thirty percent (3/10) of pheochromocytomas had absolute CT washout in the adenoma range (> 60%). For MRI, pheochromocytomas were larger (5.0 ± 4.2 vs 2.0 ± 0.7 mm; p = 0.003) and had a lower chemical-shift signal intensity index and higher adrenal-to-spleen signal intensity ratio (-3.5% ± 14.3% [range, -56.3% to 12.2%] and 1.1% ± 0.1% [range, 0.9-1.3%] vs 47.3% ± 27.8% [range, -9.4% to 86.0%] and 0.51% ± 0.27% [range, 0.13-1.1%]) (p < 0.001) and higher T2-weighted signal intensity ratio (4.4 ± 2.4 vs 1.8 ± 0.8; p < 0.001). There was no statistically significant difference in contrast-enhanced MRI AUC (288.9 ± 265.3 vs 276.2 ± 129.9 seconds; p = 0.96). The ROC AUC for T2-weighted signal intensity ratio was 0.91 with values greater than 3.8 diagnostic of pheochromocytoma. CONCLUSION: In this study, the presence of intracellular lipid on unenhanced CT or chemical-shift MR images was diagnostic of adrenal adenoma. Elevated T2-weighted signal intensity ratio was specific for pheochromocytoma but lacked sensitivity. There was overlap in all other MRI and CT washout parameters.
Authors: Michael J Connolly; Matthew D F McInnes; Mohamed El-Khodary; Trevor A McGrath; Nicola Schieda Journal: Eur Radiol Date: 2017-03-13 Impact factor: 5.315
Authors: Nicola Schieda; Matthew S Davenport; Ivan Pedrosa; Atul Shinagare; Hersch Chandarana; Nicole Curci; Ankur Doshi; Gary Israel; Erick Remer; Jane Wang; Stuart G Silverman Journal: J Magn Reson Imaging Date: 2019-01-28 Impact factor: 4.813
Authors: Joseph M Pappachan; Nyo Nyo Tun; Ganesan Arunagirinathan; Ravinder Sodi; Fahmy W F Hanna Journal: Curr Hypertens Rep Date: 2018-01-22 Impact factor: 5.369
Authors: Lucinda M Gruber; Veljko Strajina; Irina Bancos; M Hassan Murad; Benzon M Dy; William F Young; David R Farley; Melanie L Lyden; Geoffrey B Thompson; Travis J McKenzie Journal: Gland Surg Date: 2020-04
Authors: Jorge A Carrasquillo; Clara C Chen; Abhishek Jha; Alexander Ling; Frank I Lin; Daniel A Pryma; Karel Pacak Journal: J Nucl Med Date: 2021-08-01 Impact factor: 10.057